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Receptor Ser/Thr protein kinases are candidates for sensors that govern developmental changes and disease processes
of Mycobacterium tuberculosis (Mtb), but the functions of these kinases are not established. Here, we show that Mtb
protein kinase (Pkn) D overexpression alters transcription of numerous bacterial genes, including Rv0516c, a putative
anti-anti–sigma factor, and genes regulated by sigma factor F. The PknD kinase domain directly phosphorylated
Rv0516c, but no other sigma factor regulator, in vitro. In contrast, the purified PknB and PknE kinase domains
phosphorylated distinct sigma regulators. Rather than modifying a consensus site, PknD phosphorylated Rv0516c in
vitro and in vivo on Thr2 in a unique N-terminal extension. This phosphorylation inhibited Rv0516c binding in vitro to a
homologous anti-anti–sigma factor, Rv2638. These results support a model in which signals transmitted through PknD
alter the transcriptional program of Mtb by stimulating phosphorylation of a sigma factor regulator at an
unprecedented control site.
Citation: Greenstein AE, MacGurn JA, Baer CE, Falick AM, Cox JS, et al. (2007) M. tuberculosis Ser/Thr protein kinase D phosphorylates an anti-anti–sigma factor homolog. PLoS
Pathog 3(4): e49. doi:10.1371/journal.ppat.0030049
Introduction
Mycobacterium tuberculosis (Mtb) is among the world’s most
harmful pathogens, causing approximately two million deaths
annually [1]. In addition to the emergence of multi-drug–
resistant strains, Mtb evades current therapeutics by shifting
from active infection to a persistent, metabolically dormant
state [2]. This transition exemplifies the distinctive Mtb life
cycle, which encompasses unique developmental adaptations
to distinct environments [3]. Little is known about the
signaling mechanisms that mediate the biochemical changes
that initiate and maintain the stages of Mtb development.
Candidate regulators of Mtb development include receptor
Ser/Thr protein kinases (STPKs) that modulate intracellular
events in response to external stimuli. In eukaryotes,
homologous STPKs sense environmental cues and transduce
signals that regulate virtually all aspects of cell physiology.
The Mtb genome encodes 11 such Hanks-type (also called
‘‘eukaryotic-like’’) STPKs, including nine putative transmem-
brane receptor kinases [4]. Although the activating stimuli for
these kinases have not been identified, the extracellular C-
terminal sensor domains include a b-propeller interaction
motif, a PASTA repeat thought to bind cell wall structures,
and a redox-sensitive DsbG homolog [5–8]. The intracellular,
N-terminal kinase domains structurally resemble eukaryotic
homologs, and similar receptor STPKs are widely distributed
in bacterial genera. The first reported bacterial STPK
substrates include pThr-binding forkhead-associated (FHA)
domains [9], metabolic enzymes [10], and apparent regulators
of cell division [11,12], but the mechanisms of signaling in
vivo are not established. Genetic studies suggest that two of
the 11 Mtb STPKs are essential for growth [13] and that the
STPKs regulate characteristics such as cell shape [11],
virulence [14], and nitrogen balance [15]. Identifying the
intracellular targets of Mtb STPKs is essential to under-
standing their mechanistic roles in Mtb biology.
A second class of bacterial Ser/Thr kinases, the anti–sigma
factors, regulates gene expression by controlling alternative
sigma factors [16]. Alternative sigma factors, such as sigma B
(SigB) and sigma F (SigF) in Bacillus subtilis, mediate tran-
scriptional responses to environmental cues by binding RNA
polymerase and mediating promoter recognition. Work on B.
subtilis has established the paradigm by which complex
regulatory cascades influence alternative sigma factor activity
(reviewed by Hughes and Mathee [16]). Anti–sigma factor
proteins (e.g., RsbW) directly sequester cognate alternative
sigma factors and prevent RNA polymerase binding. Anti-
anti–sigma factors (e.g., RsbV) relieve this transcriptional
repression by binding the anti–sigma factor. The anti–sigma
factors phosphorylate anti-anti–sigma factors on a conserved
Ser or Thr, and this modification promotes dissociation of
the complex.
This basic regulatory organization is recapitulated for
multiple layers in which paralogs of anti–sigma factors and
anti-anti–sigma factors switch partners and ultimately deter-
mine the concentration of the active sigma factor [17]. In this
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‘‘partner switching’’ mechanism, anti–sigma factor paralogs
play two distinct roles. Some anti–sigma factors (e.g., RsbW)
antagonize transcription by directly sequestering alternative
sigma factors. In contrast, other anti–sigma factors (e.g.,
RsbT) act upstream to stimulate transcription by binding and
activating the master ‘‘environmental sensing’’ phosphatase
(RsbU in B. subtilis [18]). This phosphatase reactivates anti-
anti–sigma factors, which bind the cognate anti–sigma factor,
thus increasing the concentration of free sigma factor.
Environmental cues affect the phosphorylation state of
upstream anti-anti–sigma factor paralogs (such as RsbS and
the RsbRA-D proteins), and these proteins form a complex
(termed the ‘‘stressosome’’) that binds the positive regulator
of the phosphatase [19]. The central role of Ser/Thr
phosphorylation in anti-anti–sigma factor regulation and
the established role of eukaryotic kinases in gene regulation
led us to test the hypothesis that the eukaryotic-like STPKs
may impinge on transcription regulated by alternative sigma
factors.
Here, we demonstrate that increasing the activity of the
PknD STPK in Mtb resulted in specific phosphorylation of a
single anti-anti–sigma factor homolog, Rv0516c. Simultane-
ously, the Rv0516c gene was activated and transcription of
genes regulated by the SigF alternative sigma factor was
coordinately altered. PknD phosphorylated Rv0516c at a
novel site, Thr2, distinct from conserved Ser/Thr phosphor-
ylation sites in the anti-anti–sigma factor family. Thr2
phosphorylation abolished binding to another anti-anti–
sigma factor. These results demonstrate that PknD phosphor-
ylates a putative sigma factor regulator in Mtb, alters binding
of a cognate regulator, and, by a mechanism that has not been
determined, changes the expression of SigF-dependent genes.
Results
To investigate the pathways regulated by receptor STPK
signaling, we constructed Mtb strains expressing either wild-
type (WT) or kinase-dead (Asp138Asn) PknD under the
control of an acetamide-inducible promoter [20]. The
Asp138Asn mutation in the catalytic site reduced the in vitro
activity of kinase domain ;2,600-fold (Figure S1). In this
approach, excess kinase substituted for an activating signal to
stimulate downstream pathways. Western blotting with anti-
PknD and anti-pThr antibodies showed that the WT or
mutant kinases accumulated after induction and produced a
concomitant increase in Thr phosphorylation (Figure 1A).
Expression of the attenuated Asp138Asn mutant produced a
much smaller increase in phosphorylation of cellular targets.
Consistent with the idea that the expressed PknD (directly or
indirectly) mediated the observed phosphorylation in vivo,
cellular–protein phosphorylation was blocked when the PknD
variants were induced in the presence of SP600125 (Figure
S1B), a c-Jun N-terminal kinase (JNK) inhibitor that shows
specificity for PknD over other Mtb STPKs (C. Mieczkowski
and T. Alber, unpublished data).
Transcriptional profiling using microarrays confirmed the
induction of PknD transcripts and revealed a set of genes
regulated by PknD overexpression in a kinase-dependent
manner (Figure 1B; Table S1). Remarkably, the transcripts
most differentially expressed in the strain expressing WT
PknD (Figure 1B) included the genes with the largest
reductions in transcription during log phase growth of an
Mtb mutant harboring a deletion of sigF [21]. Moreover, the
Rv0516c gene, which is homologous to anti-anti–sigma
factors, was dramatically induced by PknD overexpression.
The established role of phosphorylation in anti-anti–sigma
factor regulation supported the hypothesis that PknD
specifically phosphorylates Rv0516c.
To test this idea, we measured the phosphorylation by the
purified PknD kinase domain of all predicted Mtb homologs
of the B. subtilis alternative sigma factor regulators. Potential
regulators were identified using iterative PSI-BLAST searches
for homologs of Rv0516c, SpoIIAA, and SpoIIAB, and
putative homologs were confirmed using 3D-PSSM [22] to
verify that the predicted fold resembled anti– or anti-anti–
sigma factors (Figure 2). All of the identified sigma factor
regulators were cloned, expressed in Escherichia coli, and
purified. Using a [c-32P]ATP transfer assay, we found that the
PknD kinase domain (PknD1–378) efficiently phosphorylated
Rv0516c, but not any of the other sigma factor regulator
homologs (Figure 3A). The SP600125 inhibitor blocked this
Rv0516c phosphorylation (Figure 3B) in a dose-dependent
manner, indicating that PknD catalyzed the observed phos-
phorylation. Rv0516c phosphorylation was reversed by PstP
(Figure 3C), the Mtb protein Ser/Thr phosphatase that
dephosphorylates all Mtb STPK substrates tested to date
[23]. These results showed that PknD and PstP act on the
putative anti-anti–sigma factor Rv0516c in vitro.
To determine if Mtb UsfX (Rv3287c), the anti–sigma factor
Ser kinase that controls SigF [24], also phosphorylates
Rv0516c, we incubated these proteins under conditions in
which UsfX phosphorylated the model substrate, myelin basic
protein (MyBP). In contrast to PknD, UsfX failed to
phosphorylate Rv0516c (Figure S2). The anti–sigma factor
paralogs RshA [25] and Rv0941c also failed to phosphorylate
Rv0516c (unpublished data). Thus, unlike anti-anti–sigma
factors that are phosphorylated by anti–sigma factors,
Rv0516c is phosphorylated by a eukaryotic-like STPK, PknD.
To determine if sigma factor regulator phosphorylation is a
general function of Mtb STPKs, we assayed the ability of four
other Mtb kinase domains (PknA, PknB, PknE, and PknK) to
phosphorylate Rv0516c and the eight other purified Mtb
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Author Summary
Many bacteria, including Mycobacterium tuberculosis (Mtb), sense the
environment using a family of signaling proteins called Ser/Thr
protein kinases (STPKs), but the functions of these sensors are not
well understood. This study shows that the Mtb protein kinase (Pkn)
D STPK attaches a phosphate group to one and only one member of
a family of regulators of ‘‘alternative’’ sigma factors, which activate
sets of genes in numerous bacteria. Phosphorylation of the regulator
at an unprecedented position abolished binding in vitro to a
putative partner. Remarkably, increasing PknD activity in Mtb not
only strongly activated the gene encoding the specific regulatory
protein phosphorylated by PknD, but also altered the expression of
genes controlled by an alternative sigma factor. By providing
evidence for a mechanistic link between PknD and gene regulation,
this work supports a new model in which STPKs in numerous
microorganisms transduce environmental signals by controlling
expression of specific groups of genes. Thus, certain bacterial STPKs
may orchestrate aspects of the coordinate control of gene
expression essential for adaptation in the environment and in host
infections.
sigma factor regulators. At concentrations of each kinase
domain equally active in phosphorylating the nonspecific
substrate, MyBP, Rv0516c was phosphorylated most effi-
ciently by PknD, and to a lesser extent by PknB and PknE
(Figures 3D and S3). Neither PknA nor PknK phosphorylated
any of the sigma factor regulators in vitro. PknB and PknE
also phosphorylated the anti–sigma factor RshA (Rv3221A).
The role of this phosphorylation remains to be determined,
as the phosphorylation of an anti–sigma factor has not been
described previously. PknE weakly phosphorylated Rv1904
and RsfA (Rv1365c). The five kinase domains tested failed to
phosphorylate any of the other sigma factor regulators. The
specific in vitro phosphorylation of Rv0516c by the PknD
kinase domain correlated with the transcriptional stimulation
of Rv0516c by PknD in vivo.
To explore the mechanism of PknD regulation of Rv0516c,
we determined the site of Rv0516c phosphorylation by mass
spectrometry and protein sequencing (Figure 4). Electrospray
ion-trap mass spectrometry revealed a molecular mass of
17,392.4 6 1 for purified, recombinant Rv0516c phosphory-
lated to completion in vitro using the PknD kinase domain.
This mass corresponded to mono-phosphorylated Rv0516c
(the expected MR of the unphosphorylated protein is
17,312.7). Matrix-assisted laser desorption ionization (MAL-
DI) tandem time-of-flight (TOF) analysis of trypsin-digested
phospho-Rv0516c indicated that the peptide consisting of the
N-terminal nine residues was the only phosphopeptide
(Figure 4A). Tandem MS and N-terminal sequencing showed
that Thr2 accounted for all of the Rv0516c phosphorylation
(Figure 4B). Eight Rv0516c N-terminal mutants—individual
Ala substitutions of the five Ser or Thr residues in the N-
terminal segment as well as deletions of up to eight residues—
were created to confirm phosphorylation at Thr2 (Figure 4C).
As expected, PknD failed to phosphorylate the Thr2Ala
Rv0516c and the two deletion mutants lacking Thr2. The
Thr7Ala variant showed a reduction in phosphorylation,
suggesting that Thr7 plays a role in kinase binding and
recognition. These data demonstrated that PknD phosphor-
ylates Rv0516c on a unique N-terminal site, Thr2.
To determine if PknD phosphorylates Rv0516c at Thr2 in
vivo, we constructed Mtb strains that co-expressed Rv0516c
(WT or Thr2Ala fused to a C-terminal 3XFLAG tag and
expressed using a GroEL promoter) and full-length PknD
(WT or kinase-dead with no tag expressed using an
acetamide-inducible promoter). Western blots confirmed
equivalent Rv0516c and PknD overexpression in each strain
(Figure 5A). Using anti–phospho-Thr antibodies, we found
that Rv0516c was efficiently phosphorylated only in the strain
overexpressing WT PknD and WT Rv0516c. Mutations that
inhibited PknD (Asp138Asn) or eliminated the Rv0516c in
vitro phosphorylation site (Thr2Ala) abolished this phosphor-
ylation of recombinant Rv0516c in Mtb. These data indicated
that PknD phosphorylated Rv0516c on Thr2 in vivo when
both proteins were overexpressed.
Although some anti-anti–sigma factor homologs of
Rv0516c are known to be regulated by phosphorylation,
Thr2 differs from the consensus phosphorylation sites in the
anti-anti–sigma factor family. In Rv0516c, Gly80 occupies the
position of the consensus Ser or Thr phosphorylation site,
which occurs, for example, at Ser58 of SpoIIAA (Figure S4A).
This consensus Ser/Thr phosphorylation site is conserved in
only two of the six Mtb anti-anti–sigma factor domains
(Figure S4B), but oxidation of cysteine at this position plays a
key regulatory role for at least Rv1365c [24]. The Rv0516c
peptide containing the corresponding segment was identified
exclusively in an unphosphorylated form (unpublished data)
in our MS analysis of PknD-phosphorylated Rv0516c. The
Figure 1. Efficient Overexpression of PknD and Concomitant Induction
of Rv0516c in Logarithmically Growing Mtb
(A) Western blots showing kinase levels (anti-PknD) and kinase activity
(anti-phosphothreonine) at 0, 2, 4, 8 and 24 h after induction of WT and
Asp138Asn PknD (D138N). As a loading control, the amount of the KatG
protein present at a constant level was monitored using anti-KatG
antibodies. Addition of the inducer (acetamide) to WT Mtb (lacking an
inducible PknD gene) caused no discernable change in the pattern of
phosphoproteins (unpublished data). The presence of a band at the
molecular weight of phosphorylated WT PknD at time zero may indicate
that the kinase was already expressed (and autophosphorylated) at low
levels in the absence of inducer. In contrast, phosphorylated Asn138Asn
PknD accumulated only after the inducer was added.
(B) Cluster diagram showing the eight genes with the largest time-
dependent changes in transcript levels upon PknD induction. Expression
levels are shown relative to a reference pool in which equal amounts of
RNA from each sample were mixed and the value at time zero was
normalized to 1.0. Microarray analysis revealed .2-fold induction or
repression of 137 genes (Table S1). Among the eight most altered
transcripts shown here, we observed robust induction (blue) of the
putative anti-anti–sigma factor Rv0516c. Rv0516c expression increased
much more upon expression of WT PknD than the attenuated mutant
(Asp138Asn). Genes labeled in red are among those most reduced in
expression during logarithmic phase growth of an Mtb sigF knockout
mutant [21]. Color unit is fold change of gene expression.
doi:10.1371/journal.ppat.0030049.g001
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absence of a Ser or Thr at the consensus phosphorylation site
and our failure to observe Rv0516c phosphorylation by any
anti–sigma factor in vitro are consistent with PknD phos-
phorylation at the distinct site, Thr2.
A yeast two-hybrid analysis of interactions among Mtb
sigma factor regulators has suggested that Rv0516c can bind
the homologous predicted anti-anti–sigma factor, Rv2638
[18]. To test this association and investigate the role of Thr2
phosphorylation in regulating the interaction, we used
affinity chromatography to compare binding of purified
Rv2638 to Rv0516c before and after PknD phosphorylation.
Rv2638 bound Rv0516c, and Rv0516c phosphorylation by
PknD abolished this association (Figure 5B). These results
showed that Thr2 phosphorylation regulates the interaction
in vitro between Rv0516c and the anti-anti–sigma factor
paralog, Rv2638.
Discussion
Because the identity of activating environmental signals
remains unknown, we stimulated PknD receptor kinase
activity in Mtb by overexpressing the protein (Figure 1A).
Overexpression was expected to stimulate phosphorylation of
PknD substrates directly by increasing the concentration of
the kinase and indirectly by favoring dimerization (by mass
action), which leads to allosteric activation [26]. PknD activity
produced a transcriptional response that altered genes
activated by SigF during log phase growth (Figure 1B),
including the anti-anti–sigma factor homolog Rv0516c [21].
Strikingly, the PknD kinase domain also directly phosphory-
lated the Rv0516c protein (but none of the other Mtb sigma
factor regulators) in vitro and upon overexpression in vivo. In
contrast to the conserved internal phosphorylation sites
found in many anti-anti–sigma factors [16], PknD phosphory-
lated Rv0516c on Thr2 in an N-terminal extension similar to
that found in two additional mycobacterial anti-anti–sigma
factors, Rv1904 and Rv2638. Phosphorylation directly
blocked Rv0516c binding to Rv2638, indicating that Thr2
phosphorylation has a direct functional consequence.
Although the roles of the Rv0516c:Rv2638 complex are
unknown, alternative phosphorylation sites and functional
interactions between upstream anti-anti–sigma factor homo-
logs have been demonstrated in B. subtilis for the RsbS and
RsbRA–RsbRD regulators [17,27–29]. These B. subtilis regu-
lators form a large complex that controls the environmental
sensing phosphatase RsbU, which dephosphorylates anti-
anti–sigma factors [17,27–29].
The correlation between SigF-responsive genes [21] and
genes that are transcriptionally sensitive to PknD activity
(Figure 1) is specific to PknD; overexpression of Mtb PknB
produces a distinct transcriptional response (T. Lombana, J.
MacGurn, J. Cox, and T. Alber, unpublished data). Nonethe-
less, these data do not demonstrate a direct mechanistic link
between Rv0516c and SigF. To the contrary, the lack of
Rv0516c phosphorylation by the Mtb anti-SigF (UsfX,
Rv3287c) or any other anti–sigma factor hints that PknD
indirectly influences SigF-mediated transcription by phos-
phorylating Rv0516c or other substrates. The present data do
not distinguish models in which repression of the SigF
response is caused by Rv0516c phosphorylation or by a
distinct signal generated by phosphorylation of one or more
other proteins in vivo.
The substrates of the Mtb STPKs are not restricted to
transcriptional regulators. Rough estimates suggest that the
number of Ser/Thr phosphoproteins in Mtb may exceed 100
[30], and proposed Mtb substrates include metabolic enzymes
[31], regulatory proteins [12,32], and membrane channels
[33]. Using proteomic methods to analyze lysates phosphory-
lated in vitro by the PknD kinase domain, Perez and
coworkers recently reported that PknD phosphorylates
MmpL7, the transporter for phthiocerol dimycocerosate
(PDIM), a lipid essential for virulence [34]. These studies,
however, did not test whether MmpL7 is phosphorylated in
vivo, whether phosphorylation altered the function of
MmpL7, or whether MmpL7 is a better substrate of other
STPKs. Perez and coworkers did not detect PknD phosphor-
ylation of Rv0516c, perhaps because this regulatory protein
Figure 2. Mtb Proteins Containing Domains Homologous to the B. subtilis Alternative Sigma Factor Regulators SpoIIAA and SpoIIAB
Four of the Mtb homologs of the B. subtilis SpoIIAB (anti–sigma factor) or SpoIIAA (anti-anti–sigma factor) encode proteins that have been shown to
regulate SigF or SigH. Rv0941c contains both types of domain, and Rv1364c contains both domains as well as an RsbU-like, Ser/Thr phosphatase domain.
Three of the seven anti-anti–sigma factor domains are preceded by a Ser/Thrrich N-terminal extension (blue). This extension in Rv0516c contains the site
of PknD phosphorylation.
doi:10.1371/journal.ppat.0030049.g002
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may not be sufficiently abundant in the Mtb lysates or
because proteins ,20 kDa (such as Rv0516c) were run off the
two-dimensional gels used to identify potential substrates
[34]. Similar reasons may explain the failure of Perez and
coworkers to detect phosphorylation of small proteins
containing FHA domains previously found to be in vitro
substrates of PknD [9].
In contrast, the complementary approach used here, based
on assaying the biochemical and transcriptional effects of
kinase activation in vivo, is sensitive to changes in the activity
of regulatory factors, even proteins present in small amounts.
By assaying in vitro PknD phosphorylation of all the Mtb
homologs of the B. subtilis SpoIIAA and SpoIIAB sigma factor
regulators, we found that only Rv0516c was efficiently
phosphorylated (Figure 3). Nonetheless, overexpressing PknD
may cause abnormal phosphorylation or physiological
changes that result in indirect transcriptional changes
unrelated to normal kinase functions. The striking correla-
tion between PknD phosphorylation of Rv0516c and activa-
tion of the Rv0516c gene, however, suggests a potential
autoregulatory loop and sets the stage to explore the
biological roles of this sigma factor regulator and the
consequences of Rv0516c phosphorylation in vivo.
Although bacterial STPKs phosphorylate many types of
Figure 3. PknD Specifically Phosphorylates Rv0516c In Vitro
(A) Each anti–sigma factor or anti-anti–sigma factor (gene [Rv] number
listed along the top) fused to MBP was cloned, expressed, purified, and
incubated with (þ) or without () PknD in a [c-32P]ATP transfer assay. The
assay was quenched with EDTA, and TEV protease was added to separate
the MBP tag from the sigma factor regulator. The two dark bands in the
center of each PknD lane correspond to the autophosphorylated kinase
and the MBP tag. The sigma factor regulators released by TEV protease
are between 12 and 20 kDa. Only Rv0516c was phosphorylated by PknD.
(B) Dose-dependent attenuation by the PknD inhibitor, SP600125, shows
that PknD phosphorylates Rv0516c.
(C) PstP, a protein Ser/Thr phosphatase from Mtb, dephosphorylates
Rv0516c. PknD (lane 1), but not heat-inactivated PknD (lane 2),
phosphorylated Rv0516c. PstP was added to PknD-phosphorylated
Rv0516c, and the phosphatase reaction was quenched immediately
(lane 3) or after 30 min (lane 4).
(D) In vitro kinase assays were performed to investigate the specificity of
five Mtb kinases for the eight sigma factor regulators (Figure S3). Assays
were carried out in a manner identical to the assay shown in Figure 3A.
Kinase concentrations were adjusted to catalyze equal phosphorylation
of myelin basic protein in vitro. PknB, PknD, and PknE phosphorylated a
specific subset of substrates.
doi:10.1371/journal.ppat.0030049.g003
Figure 4. PknD Phosphorylates Rv0516c on Thr2 In Vitro
(A) Mass spectrometry of trypsin-digested, PknD-phosphorylated
Rv0516c indicated the presence of a single phosphorylation site within
the N-terminal nine residues. The figure shows the mass spectrum of an
HPLC fraction of the digest. The measured mass (monoisotopic MHþ) of
the N-terminal peptide (1384.60 Da [arrow]) was 79.97 Da larger than the
expected mass of 1,304.63 Da, corresponding to addition of a single
phosphate group. Tandem MS and N-terminal sequencing of the peptide
at m/z 1,384.60 revealed Thr2 as the site of phosphorylation.
(B) Rv0516c Thr2 occurs in a unique, 28-residue Ser/Thr-rich, N-terminal
extension, not in the anti-anti–sigma factor domain.
(C) Mutations in the N-terminus of Rv0516c confirm that PknD
phosphorylates Rv0516c on Thr2. The eight indicated mutants of
Rv0516c were purified, and in vitro phosphorylation by the PknD kinase
domain was assayed after cleavage with the TEV protease (left). Non-
native residues before the start of Rv0516c left after TEV protease
cleavage are shaded in gray. Protein-stained loading controls (center)
confirmed that an equal amount of each Rv0516c variant was assayed.
Controls lacking kinase showed that the phosphorylation was due to
PknD (far right). Thr2Ala (T2A) and deletions of the N-terminal four and
eight residues caused the most dramatic reductions in phosphorylation.
doi:10.1371/journal.ppat.0030049.g004
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proteins [30], alternative sigma factor regulators may be
substrates of STPKs in diverse genera. In addition to the
activity of PknD, the PknB and PknE kinase domains
phosphorylated sigma factor regulators in vitro (Figures 3D
and S3). In contrast, some kinase domains (e.g., PknA and
PknK; Figure 3D) apparently do not phosphorylate these
sigma factor regulators. With up to 12 candidate alternative
sigma factors in the Mtb genome, it is unlikely that each
kinase controls a completely autonomous pathway. Instead,
our data suggest that phosphorylation pathways may con-
verge on overlapping sets of regulators (Figure 3D). The
specific phosphorylation of Rv0516c on a novel functional
site by PknD suggests that STPK phosphorylation of sigma
factor regulators goes beyond the paradigm established to
date in B. subtilis.
Materials and Methods
Bacterial strains, media, and growth conditions. The strains and
plasmids used in this study are listed in Table 1. M. tuberculosis
(Erdman) cultures were grown in 7H9 medium and transformed as
previously described [35]. Plasmids were maintained episomally by
growth in medium containing antibiotics.
Microarrays: Data collection and analysis. Strains were grown to
mid-log phase in 7H9 media before induction of PknD by addition of
acetamide (0.2%). RNA was isolated from cultures at indicated time
points as previously described [36] and quantified by measuring
OD260. RNA was random-primed and reverse transcribed in the
presence of amino-allyl dUTP. Residual RNA was hydrolyzed by
addition of 0.2 N NaOH, 0.1 M EDTA, and incubation at 65 8C for 15
min, followed by addition of 0.2 N HCl to neutralize. The cDNA was
purified with Zymo binding columns (Zymo Research, http://www.
zymoresearch.com) and conjugated to either Cy3 (individual cDNA
samples) or Cy5 (common reference pool cDNA). An equal quantity
of each RNA sample within an experiment (representing both Mtb
strains at all time points) was used to make a common cDNA
reference pool. Dye-conjugated cDNA from each individual sample
was mixed and co-hybridized with dye-conjugated cDNA from the
common reference pool on microarray slides containing oligonucleo-
tide spots representing every gene in M. tuberculosis (Qiagen, http://
www.qiagen.com). After 2 d of hybridization at 63 8C, arrays were
washed and scanned using a GenePix 3000B scanner (Axon Instru-
ments, http://www.moleculardevices.com). Array gridding was per-
formed in GenePix Pro 4.1, and Nomad 2.0 was used to select high
quality spots. For each spot, the ratio of medians (Rm) was averaged
from repeat hybridizations and normalized to t ¼ 0 (uninduced).
Cluster analysis was performed using Cluster 3.0. Two biological
replicates were performed, and each biological replicate was
averaged over two hybridizations.
Protein expression and purification for in vitro assays. Using Mtb
H37Rv genomic DNA as a template for PCR amplification, gene
segments encoding PknB1–308, PknE1–286, and PknK1–289 were cloned
into pET-28b vectors (Novagen, http://www.emdbiosciences.com).
PknD1–378 was cloned into pET-24b (Novagen). PknA1–337 and full-
length clones of each anti–sigma factor or anti-anti–sigma factor
were inserted into the Gateway vector pHMGWA [37], which included
NH2-terminal 6X-His and maltose binding protein (MBP) tags,
followed by a tobacco etch virus (TEV) protease site. All constructs
were confirmed by DNA sequencing.
Proteins were expressed in E. coli BL21 CodonPlus (Stratagene,
http://www.stratagene.com) at 18 8C. The kinase-domain constructs
and Rv0516c were purified to homogeneity (as assayed by SDS-PAGE)
by immobilized metal affinity chromatography (IMAC) using nickel-
equilibrated HiTrap chelating Sepharose (Amersham, http://www.
amershambiosciences.com), size-exclusion chromatography using
HiLoad 26/60 Superdex 75 (Amersham), and anion-exchange chro-
matography using HiTrap Q Sepharose (Amersham). The sigma
factor regulators prepared for kinase-activity screens were purified
by nickel-IMAC (Rv0516c was purified by IMAC only for these assays
as well). The molecular weight of each sigma factor regulator, as
assayed by SDS-PAGE, corresponded to the mass predicted by the
gene sequence. Because the kinase-domain constructs autophos-
phorylated during expression, migration on SDS-PAGE was slightly
retarded.
In vitro kinase assays. The sigma factor regulators were dialyzed
into the reaction buffer (80 mM NaCl, 20 mM Tris [pH 7.5], 0.5 mM
Tris(2-carboxyethyl)phosphine hydrochloride [TCEP], 250 lM
MnCl2). In a total reaction volume of 19 ll, the final concentration
of each IMAC-purified 6X-His-MBP–tagged sigma factor regulator
was 20 lM, and the final concentration of kinase was 1.2 lM. The
reaction was initiated with the simultaneous addition of 1 lL of
[c-32P]ATP (800 Ci/mmol and 10 mCi/ml; ICN, http://www.mpbio.com)
and ATP (Sigma, http://www.sigmaaldrich.com) to final concentra-
tions of 250 nCi/ll and 50 lM, respectively. The reaction was allowed
to proceed for 2 h at room temperature and quenched by the
simultaneous addition of EDTA to 20 mM and 7.2 lg of TEV protease.
Figure 5. PknD Phosphorylates Rv0516c on Thr2 In Vivo, and This
Phosphorylation Blocks Binding to Another Sigma Factor Regulator
(A) Western blot of lysates of Mtb strains expressing full-length PknD
under the control of an acetamide-inducible promoter and constitutively
expressing Rv0516c with a C-terminal, FLAG epitope tag. As controls, the
kinase was rendered inactive (D138N) or the Rv0516c phosphorylation
site was mutated (Thr2Ala [T2A]). The active (but not the mutant) PknD
phosphorylated the overexpressed WT Rv0516c. The levels of endoge-
nous proteins were too low to detect phosphorylated Rv0516c in this
experiment. KatG was detected with antibodies as a loading control.
Rv0516c (but not the Thr2Ala mutant) was phosphorylated upon WT
PknD induction.
(B) Phosphorylation on Thr2 abolished binding to Rv2638. Equal amounts
of cell lysates overexpressing Rv2638 were incubated with pre-
phosphorylated (lane 4) or unphosphorylated (lane 3) Rv0516c. As a
control, Rv2638 binding to the purification tag alone was evaluated (lane
2). Protein staining was used to insure that equal amounts of
recombinant protein were used as bait in each reaction, and bound
Rv2638 was visualized by Western blotting with antibodies against the
His6 tag. Total soluble protein before incubation with the amylose-
Sepharose (lane 1) indicated the presence of Rv2638. Only unphos-
phorylated Rv0516c bound the anti-anti–sigma factor, Rv2638.
doi:10.1371/journal.ppat.0030049.g005
PLoS Pathogens | www.plospathogens.org April 2007 | Volume 3 | Issue 4 | e490480
Mtb PknD Phosphorylates a Sigma Factor Regulator
The TEV cleavage was allowed to proceed 2 h or overnight at room
temperature, resulting in efficient separation of each sigma factor
regulator from the tag. The sequence GlyHisMet was left at the NH2-
terminus after TEV cleavage of the tag. The cleavage reactions were
separated by SDS-PAGE on 4%–12% NuPage Novex BisTris gels
(Invitrogen, http://www.invitrogen.com), and the gels were dried.
Radioactivity was quantified with a Molecular Dynamics Typhoon
8600 phosphoimager.
Activity of the Asp138Asn mutant. To assess the activity of the
Asp138Asn mutant of PknD, we incubated 0.036 nM WT kinase or 3.6
nM Asp138Asn kinase with 0.5 mg/ml MyBP or 0.5 mg/ml Rv0516c.
The reaction was carried out for 30 min under buffer, metal, and ATP
concentrations similar to those described above, and then quenched
with either 5X SDS-PAGE loading dye (for MyBP) or the TEV/EDTA
mixture described above. Phosphorylation was quantified with
ImageQuant (GE Healthcare, http://www.gehealthcare.com) after
electrophoresis, drying, and phosphoimager data collection.
PknD inhibition by SP600125. Untagged PknD1–378 was purified by
IMAC, cleaved with TEV, purified on HiLoad 26/60 Superdex 75
(Amersham), and concentrated from the flow-through fraction of a
second IMAC column. Each reaction was set up with or without 38
nM kinase, 20 lM Rv0516c, 250 nCi/ll [c-32P]ATP, and 25 lM
unlabeled ATP in 50 mM NaCl, 50 mM HEPES (pH 7.5), 0.5 mM
TCEP, 10 mM MnCl2, and 10 mM MgCl2. SP600125 was diluted into
water and added to a concentration of 20 nM to 20 lM. Reactions
were carried out and analyzed as described above.
In vitro dephosphorylation of Rv0516c by PstP. PknD, Rv0516c,
and PstP were purified to homogeneity [30]. Heat-inactivated PknD
was prepared by incubation at 95 8C for 1 h. Phospho-Rv0516c
prepared in a 2-h incubation with PknD and [c-32P]ATP was treated
with 2.3 lg of PstP. The reaction was quenched with EDTA and TEV
after zero or 30 min. Separation and quantification were carried out
as described above.
Phosphorylation site mapping. Purified Rv0516c was phosphory-
lated using 6X-His-PknD1–378 and 2 mM ATP. The reaction
proceeded overnight, and the kinase was removed by IMAC. The
flow-through fraction was diluted with water and rocked at room
temperature for 2 d to induce precipitation. Supernatant was
removed, and the resulting pellet was dissolved in 6 M guanidinium
hydrochloride.
The mass of the intact protein was determined by electrospray
ionization–ion-trap mass spectrometry. Rv0516c was digested with
trypsin; the resulting digest mixture was separated on a reversed-
phase C-18 column (0.15 3 150 mm), and fractions were collected.
The MALDI TOF spectrum of each fraction was obtained, and the
phosphorylated peptide was identified using MALDI-tandem TOF
(MS/MS). The MS/MS spectrum was used, along with Edman
sequencing, to identify the phosphorylation site.
Mutations to the N-terminus of Rv0516c were created with
QuikChange (Stratagene). Proteins were purified and phosphorylated
as described, except that the Rv0516c variants were treated with TEV
protease and quenched with the protease inhibitor, aminoethyl-
benzene sulfonyl fluoride (AEBSF) (MP Biomedicals, http://
www.mpbio.com), prior to phosphorylation.
In vivo phosphorylation state analysis. Full-length PknD was
cloned into an acetamide-inducible M. tuberculosis expression vector
(pGWdest3.kan) [38]. Full-length Rv0516c (WT or mutant) was cloned
into a tuberculosis expression vector under the control of the
constitutive GroEL promoter (pGWdest1.hyg). The vector also
encoded a C-terminal antigenic FLAG (DDDDK) tag. Mutants were
made using Quikchange (Stratagene) on the Rv0516c gene in the
entry vector. Mtb Erdman was transformed by electroporation [35],
grown for 3–6 wk on solid rich medium, and single colonies were
picked and grown to mid-log phase. Large (50 mL) cultures were
inoculated and adjusted to an optical density (OD) at 600 nm of 0.3
after 5 d. To induce PknD expression, acetamide was added to a final
concentration of 0.2% at 24, 8, 4, or 2 h before harvesting. Induced
and uninduced cultures were grown to a final OD600 of ;0.6. Then,
10 mL of each culture were harvested by centrifugation, and
resuspended in 200 lL of extraction buffer (1% SDS, 20 mM EDTA,
50 mM HEPES (pH 7.5), 1 mM AEBSF). Samples were immediately
boiled for 25 min. Next, 200 lL of 100-lm glass beads were added,
and samples were bead-beaten twice for 5 min. Samples were boiled a
second time for 10 min and centrifuged. The soluble fraction was
removed and diluted with SDS-PAGE loading dye. After electro-
phoresis in 10%–20% Tris-glycine gels, proteins were transferred to
PVDF membrane, and detected with anti-phosphoThreonine (Invi-
trogen), anti-DDDDK (AbCam), anti-KatG, or anti-PknD antibodies
(Pacific Immunology, http://www.pacificimmunology.com). HRP-con-
jugated secondary antibody was used with Kodak BioMax MR film to
develop the Western blots. In cases of multiple antibody detection,
blots were stripped in 2% SDS/100 mM DTT, 62 mM Tris (pH 7), for
30 min at 50 8C.
In vitro interaction assays. Rv2638 was expressed in E. coli in the
pHxGWA (N-terminal His6-thioredoxin) vector [37]. Phosphorylated
Rv0516c was prepared by incubation of purified His6-MBP–tagged
protein with 5 mM MnCl2, 2 mM ATP, and 10:1 (w:w) PknD1–378.
Phospho-Rv0516c was purified by IMAC, and both phosphorylated
and unphosphorylated Rv0516c were dialyzed into the pull-down
buffer (70 mM NaCl, 20 mM HEPES 7.5, 0.5 mM TCEP).
Pull-downs were performed by lysing (by sonication) E. coli that
expressed Rv2638 in the presence of 200 lg MBP-tagged Rv0516c
(phosphorylated or unphosphorylated) or His6-MBP control in 70
mM NaCl, 20 mMHEPES 7.5, 0.5 mM TCEP, 1 mM AEBSF, and 10 mM
MnCl2. After rocking the lysate for 30 min at 4 8C, samples were
centrifuged for 10 min at 14,000 rpm in a microcentrifuge at 4 8C. A
small amount of the supernatant was retained for analysis, and the
majority was applied to 50 lL of amylose-Sepharose (New England
Biolabs, http://www.neb.com) pre-equilibrated in the buffer. After
rocking for 10 min at 4 8C, resin was washed three times in buffer,
Table 1. Plasmids and Strains Used in This Study
Category Plasmid/Strain Name Description/Genotype Source
Plasmids Original Gateway vector pDONR207, GentR, CmR Invitrogen
pGWdest3.kan oriE, oriM, attR1, CmR, ccdB, attR2, acetamidase promoter, KanR This study
pAG1 pGWdest3 with PknD (WT), KanR This study
pAG2 pGWdest3 with PknD (D138N), KanR This study
pGWdest1.hyg oriE, oriM, attR1, CmR, ccdB, attR2, GroEL promoter, KanR This study
pAG3 pGWdest1 with Rv0516c (WT, C9 3XFLAG), HygR This study
pAG4 pGWdest1 with Rv0516c (T2A, C9 3XFLAG), HygR This study
pAG5 pGWdest1 with Rv0516c (T2E, C9 3XFLAG), HygR This study
M. tuberculosis strains Erdman WT W. R. Jacobs, Jr.
JMM55 Erdman þ pAG1, KanR This study
JMM57 Erdman þ pAG2, KanR This study
AGM1 JMM55 þ pAG3, KanR HygR This study
AGM2 JMM57 þ pAG3, KanR HygR This study
AGM31 JMM55 þ pAG4, KanR HygR This study
AGM32 JMM55 þ pAG5, KanR HygR This study
AGM33 JMM57 þ pAG4, KanR HygR This study
AGM34 JMM57 þ pAG5, KanR HygR This study
doi:10.1371/journal.ppat.0030049.t001
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resuspended in 40 lL of 2X SDS-PAGE loading dye, and boiled for 10
min. Samples were separated on 12% Tris-glycine gels (Invitrogen),
transferred to PVDF, blocked in 4% non-fat dry milk, and incubated
overnight at room temperature with 1:2000 monoclonal anti-His6
clone HIS-1 (Sigma). Blots were washed and imaged as described
above. For loading controls, the same reactions were separated on
12% Tris-glycine gels and stained with Coomassie blue.
Supporting Information
Figure S1. Inhibition of PknD
(A) The D138N mutant of PknD is 2,600-fold less active than WT in
vitro. Using a 100-fold excess of PknD D138N, we measured a 27.2-
fold difference in Rv0516c phosphorylation, and a 25.3-fold differ-
ence in MyBP phosphorylation compared to the WT PknD kinase
domain. Values were averaged over three replicates.
(B) The PknD inhibitor SP600125 delays changes in phosphoryla-
tion upon PknD expression in Mtb. Mtb strains expressing WT (left)
or D138N PknD (right) were induced with or without the
simultaneous addition of 60 lM SP600125 and grown for 8 or 24
h. All samples were lysed at the same time, clarified by
centrifugation, separated by SDS-PAGE, and probed with anti-pThr
antibodies. The presence of the inhibitor, which is a green
compound, turned the cells green, indicating that it was likely
taken up. The WT PknD, but not the D138N mutant, was present
and phosphorylated in the uninduced cells (compare the 0 time
points). At 8 h, SP600125 inhibited cellular protein phosphorylation
by the expressed PknD. The D138N mutant PknD, however, was
phosphorylated at 8 h in the presence of the inhibitor. This
increased phosphorylation suggests that the overexpressed PknD is
phosphorylated by other cellular kinases that are not inhibited by
SP600125. By 24 h, perhaps due to overexpression of PknD or
efflux of the compound, Mtb cellular proteins are highly phos-
phorylated.
Found at doi:10.1371/journal.ppat.0030049.sg001 (239 KB PDF).
Figure S2. Rv3287c (Mtb UsfX) Phosphorylates the Model Substrate
MyBP, but Not Rv0516c
Autoradiogram showing substrate phosphorylation in the presence
(þ) and absence () of the anti–sigma factor kinase, Rv3287.
Found at doi:10.1371/journal.ppat.0030049.sg002 (44 KB PDF).
Figure S3. Multiple Mtb Ser/Thr Protein Kinases Phosphorylate a
Unique Set of Putative Sigma-Regulators
The phosphorylation of the putative anti– and anti-anti–sigma
factors by PknA, PknB, PknE, and PknK was assessed. PknD did not
phosphorylate Rv1364c (unpublished data), but this regulator was
omitted from the analysis due to the presence of a phosphatase
domain. Each kinase domain was incubated in assay buffer with
MBP-tagged substrate protein. The tag was removed with TEV
protease and the phosphoproteins were visualized by autoradiog-
raphy of SDS gels. The MBP tag was phosphorylated by the PknA,
PknB, and PknE kinase domains. The kinase-domain concentrations
were adjusted to produce similar phosphorylation of the nonspecific
substrate, MyBP. Sigma factor regulators migrated in the bottom
half of each gel. (A) PknA does not phosphorylate any sigma factor
regulators. (B) PknB phosphorylates Rv0516c and Rv3221A (RshA).
(C) PknE phosphorylates Rv0516c, Rv1365c (RsfA), Rv1904, and
Rv3221A (RshA). (D) PknK does not phosphorylate any of these
sigma factor regulators.
Found at doi:10.1371/journal.ppat.0030049.sg003 (624 KB PDF).
Figure S4. Multiple Sequence Alignment around the Conserved Anti-
Anti–Sigma Factor Phosphorylation Site
Rv0516c and other putative Mtb anti-anti–sigma factors are highly
homologous to known anti-anti–sigma factors. For example,
Rv0516c and Rv2638 align to the well-characterized RsfA (anti-
anti–sigma factor F, Rv1365c) with e-values of 2 3 105 and 1 3
1029, respectively.
(A) A multiple sequence alignment of anti-anti–sigma factors and
Rv0516c around the phosphorylation site in B. subtilis SpoIIAA
(shaded). Phosphorylation of all of these anti-anti–sigma factors has
been observed in the respective bacteria. While Rv0516c contains a
serine adjacent to the conserved phosphorylation site, the conserved
Ser/Thr is replaced with a Gly in Rv0516c.
(B) Multiple sequence alignment showing that the phosphorylation
site observed in SpoIIAA and RsbV from B. subtilis is conserved only
in two of the sixMtb anti-anti–sigma factor domains. Oxidation of the
highlighted cysteine in Rv1365c has been shown to mimic the
physiological role of Ser phosphorylation.
Found at doi:10.1371/journal.ppat.0030049.sg004 (21 KB PDF).
Table S1. Genes Differentially Regulated in Response to Over-
expression of WT or Kinase-Dead PknD
For each gene at each time point, the value in the table represents the
(averaged) ratio of medians (Rm) which has been normalized to the
Rm at t ¼ 0. Rm is defined as the median pixel intensity for the
reference pool divided by the median pixel intensity of the sample.
Genes depicted in this table exhibit at least a 2-fold difference in Rm
between WT and kinase-dead samples at any time point. The data in
the table were ordered by hierarchical clustering using Gene Cluster
3.0. N.D. indicates no data available. Genes under the control of SigF
during log phase growth (e.g., acpM, Rv1592c, and fabD) were
expressed at a lower level at t ¼ 0 in the strain harboring the WT
PknD expression plasmid compared to the kinase-dead PknD
plasmid. These genes showed little fluctuation in transcriptional
levels as WT PknD was overexpressed for 2, 8, or 24 h. In contrast, as
expression of the kinase-dead PknD increased over time, these genes
under SigF control during log phase growth were progressively
repressed to levels similar to those in the strain expressing WT PknD.
This pattern coincided with the leaky expression of active phos-
phorylated WT PknD at t ¼ 0, while kinase activity was stimulated
only after 4 h of kinase-dead PknD overexpression (Figure 1A). The
idea that active WT PknD may have been signaling in uninduced cells
is supported by the finding that the average Rm value for five
representative SigF regulated genes (acpM, Rv1592c, fabD, atpE and
sodA) at time zero in WT versus the Asp138Asn mutant strain was 1.9.
By comparison, the mean and median Rm ratios at time zero for all
genes were 1.07 and 0.96, respectively. These data suggest that some
effects of WT PknD overexpression may have been manifest at t¼0 in
these microarray experiments.
Found at doi:10.1371/journal.ppat.0030049.st001 (415 KB DOC).
Table 2. GenBank Accession Numbers of Genes Described in
This Study
Gene Rv Number Name Synonym Accession Organism
Rv0516c NP_215030 M. tuberculosis
Rv0941c NP_215456 M. tuberculosis
Rv1365c RsfA NP_215881 M. tuberculosis
Rv1904 NP_216420 M. tuberculosis
Rv2638 NP_217154 M. tuberculosis
Rv3221c RshA NP_217737 M. tuberculosis
Rv3287 UsfX NP_217804 M. tuberculosis
Rv3687 RsfB NP_218204 M. tuberculosis
Rv0015c PknA NP_214529 M. tuberculosis
Rv0014c PknB NP_214528 M. tuberculosis
Rv0931c PknD NP_215446 M. tuberculosis
Rv1743 PknE NP_216259 M. tuberculosis
Rv3080c PknK NP_217596 M. tuberculosis
Rv0018c PstP NP_214532 M. tuberculosis
Rv1364c YP_177802 M. tuberculosis
Rv3286c SigF NP_217803 M. tuberculosis
SigB NP_388354 B. subtilis
SigF NP_390226 B. subtilis
SpoIIAA NP_390228 B. subtilis
SpoIIAB NP_390227 B. subtilis
RsbS NP_388349 B. subtilis
RsbT NP_388350 B. subtilis
RsbRA RsbR NP_388348 B. subtilis
RsbRB YkoB NP_389203 B. subtilis
RsbRC YojH NP_389827 B. subtilis
RsbRD YqhA NP_390356 B. subtilis
RsbU NP_388351 B. subtilis
RsbV NP_388352 B. subtilis
RsbW NP_388353 B. subtilis
doi:10.1371/journal.ppat.0030049.t002
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Accession Numbers
Please see Table 2 for a list of genes described in this study.
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